The Impact of O6-Methylguanine-DNA Methyltransferase (<i>MGMT</i>) Promoter Methylation on the Outcomes of Patients with Leiomyosarcoma Treated with Dacarbazine.

Cells · 2023 · PMC10296876 · PMID 37371106

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

close to significanceno p-value reported

The Kaplan Meier plot of PFS showed a difference close to significance between patients with unmethylated MGMT , median PFS = 8.84 (95% CI: 6.80–16.4) and patients with methylated MGMT , median = 4.73 (95% CI: 3.38–NA), (2.2 (1.00–4.8), p = 0.052).

also in 2,130 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.